Literature DB >> 2791347

Determinants of genetic susceptibility in HLA-associated autoimmune disease.

G T Nepom1.   

Abstract

The predominant genetic elements contributing to HLA-associated disease susceptibility have been localized within the HLA-D, or class II, region of the major histocompatibility complex for a large number of autoimmune diseases. Two likely candidate susceptibility genes in this region have been identified: the DQ beta 3.2 gene is the single allele most highly associated with type I diabetes (IDDM) and accounts for the HLA-DR4 association with that disease. DNA sequence analysis and mutagenesis studies implicate a small set of key residues within the DQ3.2 molecule as critical polymorphic residues likely contributing to disease-associated immune mechanisms. Different class II genes, Dw4 and Dw14, specific alleles at the DR beta locus, account for the HLA-DR4 association with rheumatoid arthritis (RA). A single cluster of polymorphic residues within the DR beta molecule may be sufficient to account for nearly all of the structural and genetic contributions of the HLA complex to the pathogenesis of RA.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2791347     DOI: 10.1016/0090-1229(89)90070-6

Source DB:  PubMed          Journal:  Clin Immunol Immunopathol        ISSN: 0090-1229


  3 in total

1.  Polymorphism of the class II gene of rat major histocompatibility complex, RT1: partial sequence comparison of the first domain of the RT1.B beta 1 alleles.

Authors:  H Fujii; M Kakinuma; T Yoshiki; T Natori
Journal:  Immunogenetics       Date:  1991       Impact factor: 2.846

2.  HLA-DQB1 polymorphism determines incidence, onset, and severity of collagen-induced arthritis in transgenic mice. Implications in human rheumatoid arthritis.

Authors:  D S Bradley; G H Nabozny; S Cheng; P Zhou; M M Griffiths; H S Luthra; C S David
Journal:  J Clin Invest       Date:  1997-11-01       Impact factor: 14.808

3.  B cells are important as antigen presenting cells for induction of MHC-restricted arthritis in transgenic mice.

Authors:  Veena Taneja; Christopher J Krco; Marshall D Behrens; Harvinder S Luthra; Marie M Griffiths; Chella S David
Journal:  Mol Immunol       Date:  2007-02-14       Impact factor: 4.407

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.